| Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil SV Katikireddi, T Cerqueira-Silva, E Vasileiou, C Robertson, S Amele, ... The Lancet 399 (10319), 25-35, 2022 | 135 | 2022 |
| Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26. COV2. S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study T Cerqueira-Silva, JR Andrews, VS Boaventura, OT Ranzani, ... The Lancet Infectious Diseases 22 (6), 791-801, 2022 | 112 | 2022 |
| Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial MAD Silveira, D De Jong, AA Berretta, EB dos Santos Galvão, JC Ribeiro, ... Biomedicine & Pharmacotherapy 138, 111526, 2021 | 112* | 2021 |
| Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil T Cerqueira-Silva, SV Katikireddi, V de Araujo Oliveira, R Flores-Ortiz, ... Nature Medicine 28 (4), 838-843, 2022 | 108 | 2022 |
| Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study T Cerqueira-Silva, V de Araújo Oliveira, VS Boaventura, JM Pescarini, ... The Lancet Regional Health–Americas 6, 2022 | 85* | 2022 |
| Vaccination plus previous infection: protection during the omicron wave in Brazil T Cerqueira-Silva, V de Araujo Oliveira, ES Paixão, PTV Florentino, ... The Lancet Infectious Diseases 22 (7), 945-946, 2022 | 48 | 2022 |
| Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study PTV Florentino, T Millington, T Cerqueira-Silva, C Robertson, ... The Lancet Infectious Diseases 22 (11), 1577-1586, 2022 | 46* | 2022 |
| Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period PTV Florentino, FJO Alves, T Cerqueira-Silva, VA Oliveira, JBS Júnior, ... Nature communications 13 (1), 4756, 2022 | 42 | 2022 |
| Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil T Cerqueira-Silva, V de Araujo Oliveira, ES Paixão, JB Júnior, GO Penna, ... Nature communications 13 (1), 4154, 2022 | 31 | 2022 |
| CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study ES Paixao, KLM Wong, FJO Alves, V de Araújo Oliveira, ... BMC medicine 20 (1), 146, 2022 | 24* | 2022 |
| LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes I Bonyek-Silva, AFA Machado, T Cerqueira-Silva, S Nunes, MR Silva Cruz, ... Diabetes 70 (9), 2120-2130, 2021 | 23 | 2021 |
| A clinical scoring system to predict long-term arthralgia in Chikungunya disease: A cohort study L de Moraes, T Cerqueira-Silva, V Nobrega, K Akrami, LA Santos, C Orge, ... PLoS Neglected Tropical Diseases 14 (7), e0008467, 2020 | 19 | 2020 |
| Association between risk of obstructive sleep apnea and cerebrovascular reactivity in stroke patients RC Castello‐Branco, T Cerqueira‐Silva, AL Andrade, BMM Gonçalves, ... Journal of the American Heart Association 9 (6), e015313, 2020 | 19 | 2020 |
| Bridging learning in medicine and citizenship during the COVID-19 pandemic: a telehealth-based case study T Cerqueira-Silva, R Carreiro, V Nunes, L Passos, BF Canedo, S Andrade, ... JMIR public health and surveillance 7 (3), e24795, 2021 | 15 | 2021 |
| Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group AB Cazé, T Cerqueira-Silva, AP Bomfim, GL de Souza, ACA Azevedo, ... Journal of Global Health 13, 2023 | 13* | 2023 |
| Burnout syndrome and resilience in medical students from a Brazilian public college in Salvador, Brazil AR Dias, SM Fernandes, I Fialho-Silva, T Cerqueira-Silva, ... Trends in psychiatry and psychotherapy 44, e20200187, 2022 | 13 | 2022 |
| Oral lesions are frequent in patients with Chikungunya infection PM Casais, K Akrami, T Cerqueira-Silva, LP Moraes, VN Rigaud, ES Neto, ... Journal of Travel Medicine 27 (4), taaa040, 2020 | 11 | 2020 |
| Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test … T Cerqueira-Silva, SA Shah, C Robertson, M Sanchez, SV Katikireddi, ... PLoS medicine 20 (1), e1004156, 2023 | 10* | 2023 |
| Metabolic disorders and post-acute hospitalization in black/mixed-race patients with long COVID in Brazil: A cross-sectional analysis APA Barreto, MA Barreto Filho, LC Duarte, T Cerqueira-Silva, A Camelier, ... Plos one 17 (10), e0276771, 2022 | 9* | 2022 |
| Chagas disease is an independent predictor of stroke and death in a cohort of heart failure patients T Cerqueira-Silva, BMM Gonçalves, CB Pereira, LM Porto, MEL Marques, ... International Journal of Stroke 17 (2), 180-188, 2022 | 7 | 2022 |
Manoel Barral NettoFundação Oswaldo Cruz, FIOCRUZ, BrazilVerified email at fiocruz.br
